HDAX Therapeutics

Toronto, Canada

HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science

$3.2M raised

Sep 2024

Seed

Biopharma Biotechnology Life Science Pharmaceutical

Top Investors

Ontario Centre of InnovationFACITAnges QuebecSeedFolioToronto Innovation Acceleration Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about HDAX Therapeutics

How much funding has HDAX Therapeutics raised?

HDAX Therapeutics has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in September 2024.

Who are HDAX Therapeutics's investors?

HDAX Therapeutics's investors include Ontario Centre of Innovation, FACIT, Anges Quebec, SeedFolio, Toronto Innovation Acceleration Partners.

Where is HDAX Therapeutics headquartered?

HDAX Therapeutics is headquartered in Toronto, Canada.

What does HDAX Therapeutics do?

HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science

What stage is HDAX Therapeutics at?

HDAX Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2024.

MLA

"HDAX Therapeutics — Funding & Investors." VCBacked, September 5, 2024, https://www.vcbacked.co/company/hdax-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2024). HDAX Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/hdax-therapeutics

Wikipedia (cite web)

{{cite web |title=HDAX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hdax-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2024.

Similar Companies in Biopharma